21 results on '"Félix, Ana"'
Search Results
2. Quantitative assessment of myocardial fibrosis by digital image analysis: An adjunctive tool for pathologist “ground truth”
3. Left Ventricular Remodeling in Degenerative Aortic Valve Stenosis
4. Rising to the challenge? Inter-individual variation of the androgen response to social interactions in cichlid fish
5. CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer
6. Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases
7. Comprehensive Genetic Characterization of Mitochondrial Ca2+ Uniporter Components Reveals Their Different Physiological Requirements In Vivo
8. Short-Term Outcome of Spontaneous Intracerebral Hemorrhage in Algarve, Portugal: Retrospective Hospital-Based Study
9. Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease models
10. The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy
11. Danon Disease in a 14-Year-Old: An Exclusively Cardiac Phenotype
12. Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina
13. Chapter 8 - Neurologic Cases – Casos neurológicos
14. A conserved function of the chromatin ATPase Kismet in the regulation of hedgehog expression
15. Osa, a subunit of the BAP chromatin-remodelling complex, participates in the regulation of gene expression in response to EGFR signalling in the Drosophila wing
16. HPV DNA detection and genotyping in 21 cases of primary invasive squamous cell carcinoma of the vagina
17. List of Contributors
18. Site-Directed Mutagenesis of Human Immunodeficiency Virus Type 1 Reverse Transcriptase at Amino Acid Position 138
19. Laminin and collagen IV in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: An immunohistochemical study
20. Prognostic significance of biomarkers (c- erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma
21. Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2′,5′-Bis- O-( tert-butyldimethylsilyl)-β- d-ribofuranosyl]-3- N-methyl-thymine]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.